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Hot Spot Focusing of Somatic Hypermutation
in MSH2-Deficient Mice Suggests
Two Stages of Mutational Targeting
could be fixed by chromosome replication before mis-
match repair became operative. Mechanisms have also
been envisaged in which the mismatch repair process
no longer relies exclusively on the parental DNA strand
for templating its repair activity.
Cristina Rada,² Michael R. Ehrenstein,²
Michael S. Neuberger,* and CeÂ sar Milstein
Medical Research Council Laboratory of
Molecular Biology
Hills Road
Cambridge CB2 2QH With such considerations in mind, one might expect
the frequency of somatic hypermutation to be eitherUnited Kingdom
unaffected or enhanced in mismatch repair±deficient
mice. Several groups have now investigated this issue.
The first report, from Cascalho et al. (1998), strikingly
Summary
reported that the extent of V gene mutation in a putative
memory B cell population of mice carrying a targeted
Likely creation of mismatches during somatic hyper- VH gene integration was considerably reduced when an-mutation has stimulated interest in the effect of mis- alyzed in mice deficient in PMS2 (a mammalian homolog
match repair deficiency on the process. Analysis of of E. coli mutL). This led these authors to propose that
unselected mutations in the 39 flank of VH rearrange- in hypermutating B cells mismatch repair actually ªcor-
ments in germinal center B cells revealed that MSH2
rectsº nucleotide substitutions in the immunoglobulin
deficiency caused a 5-fold reduced mutation accumu-
loci according to the newly synthesized (as opposed to
lation. This might reflect ectopic effects of the Msh2
parental) DNA strand and therefore fixes the mutations
disruption; indeed, the mice exhibit other perturba-
rather than eliminates them. However, analyzing an anti-
tions within the B cell compartment. However, that
gen-specific response in immunized PMS2-deficient
MSH2 (or factors dependent upon it) plays a role in
mice, Winter et al. (1998) did not observe such a pro-
the mechanism of mutation fixation is indicated by
found reduction in mutation accumulation but rather
a strikingly increased focusing of the mutations on
noted an increase in adjacent nucleotide substitutions.
intrinsic hot spots. We propose two phases to hyper-
With regard to mice lacking MSH2 (a mammalian ho-
mutation targeting. The first is hot spot focused and
molog of mutS), both Phung et al. (1998) and Jacobs
MSH2 independent; the second, MSH2-dependent et al. (1998) detected no major effect on the mutation
phase yields a more even spread of mutation fixation. frequency of V gene segments but did note an increased
proportion of mutations occurring at Gs and Cs. In this
Introduction work, we have also analyzed hypermutation in MSH2-
deficient mice but, in this case, by looking at the accu-
Somatic hypermutation of immunoglobulin V genes mulation and distribution of the unselected mutations
plays a central role in antibody diversification and affinity in the intronic 39 flank of VH segments amplified from
maturation (for reviews see Rajewsky, 1996; Storb, 1996; Peyer's patch germinal center B cells. Unlike Jacobs et
Weill, 1996; Parham, 1998). Multiple single-nucleotide al. (1998) and Phung et al. (1998), we observe consider-
substitutions are incorporated into a roughly 2 kb do- ably diminished mutation accumulation in MSH2-defi-
main that includes the DNA that encodes the V region cient mice. In addition, the altered mutational targeting
of the expressed antibody. The molecular mechanism is revealed as a striking focusing toward intrinsic hot
of the process is not known, but most models envisage spots. Since the most dominant intrinsic hot spots are
an involvement of error-prone DNA synthesis that will at G/C, this hot spot focusing is consistent with the
likely lead to a nucleotide mismatch between the newly G/C bias noted by both these groups and discussed by
synthesized, mutated DNA strand and its template part- Phung et al. (1998). However, the finding of hot spot
ner. Were such a mismatch corrected in the conven- focusing in combination with the diminished mutation
tional manner with the newly synthesized strand being accumulation gives alternative insights into the implica-
repaired, one might envisage that the nucleotide substi- tion of the findings for models of antibody hypermu-
tutions created by the hypermutation process would tation.
be reverted to germline and that the intended effect of
immunoglobulin V gene diversification thereby abro-
Resultsgated.
Several solutions to this conundrum can be envi-
Diminished Mutation Accumulationsioned. Mismatch repair in hypermutating B cells could
To analyze immunoglobulin gene hypermutation in MSH2-be suppressed either globally or even locally (i.e., within
deficient mice, we used the strategy that we previouslythe vicinity of the V gene segment). Alternatively, if hy-
described to examine hypermutation in p53-deficientpermutation occured, say, during G1 with mismatch re-
animals (Jolly et al., 1997). This strategy exploits thepair being restricted to late in S or G2, the mutations
findings that (1) hypermutation is an ongoing process
in the germinal centers of mouse Peyer's patches, since
these cells are continuously responding to gut antigens*To whom correspondence should beaddressed (e-mail: msn@mrc-
(GonzaÂ lez-FernaÂ ndez and Milstein, 1993); and (2) thelmb.cam.ac.uk).
²These authors contributed equally to this work. mutation domain in the IgH locus extends downstream
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Table 1. Mutation Frequency in Peyer's Patch Germinal Center B Cells
Clones Analyzed Mutation Frequency (31023)
Total Number Total Number Calculated on the Basis of
Number Mutated of Mutations All Clones Mutated Clones
Msh22/2 121 81 164 3.36 5.0
Msh21/2 95 71 739 19.3 25.8
of the productively rearranged JH segment, well into the diminished mutation accumulation in Peyer's patches;
increased focusing on hot spots isnot a feature of hyper-JH-CH intron (Lebecque and Gearhart, 1990). This means
mutation in young, wild-type mice, although such ani-that mutation accumulation can readily be analyzed fol-
mals do show diminished mutation accumulation (leg-lowing PCR amplification of the JH flanking region with-
end to Table 2; unpublished data).out need for specific immunization or for introduction
When the nucleotide substitution preferences of theof a marked transgene substrate. Furthermore, the fact
mutations in the Msh22/2 and Msh21/2 mice are com-that only mutations in the JH-CH intron are analyzed
pared (Table 3), a marked alteration in the targetingmeans that the deduced mutation pattern gives informa-
pattern is observed. In Msh21/2 heterozygotes (as intion about the instrinsic features of the mutational pro-
wild-type mice), A residues are most frequently mutated.cess without the severe skewing effects of specific anti-
However, in the Msh22/2 littermates, there is a cleargen selection.
preference for mutations at G and less markedly at C,Peyer's patch germinal center B cells were obtained
similar to what has been noted by Phung et al. (1998)by cell sorting from litter-matched Msh22/2 and Msh21/2
and Jacobs et al. (1998). This discrepancy between amice. The JH flanking region was PCR amplified using
marked G preference in MSH2-deficient mice and anone oligonucleotide that primes forward from within
A-preference in wild-type animals is not solely apparentframework 3 of the members of the abundantly used
owing to increased mutation at the major hot spotsVHJ558 family and a second oligonucleotide that primes
(which, in the region analyzed, are themselves at G/Cbackward from a site 1.2 kb downstream of JH4. Since
residues), since the discrepancy is even evident whenthe resultant products span the VHDHJH junction, clonal
the major hot spots are excluded from the analysisrelatedness of amplified products could readily be iden-
(Table 3).tified.
Mice from two sets of litters were analyzed, and the
Altered B Cell Subpopulationsassembled results reveal a roughly 5-fold reduction in
and Immune Responsesmutation accumulation in the MSH2-deficient animals
Thus, the data reveal that in the absence of MSH2 there(Table 1). Despite variation between individuals, it is
is both dimished accumulation and altered targeting ofnotable that this reduction is not so much a conse-
somatic hypermutation, suggesting a role for the mis-quence of the fact that fewer germinal center B cells
match repair system in the molecular mechanism ofhave undergone hypermutation at all, but rather that the
mutation creation/fixation during somatic hypermuta-bulk of cells have accumulated fewer mutations (Figure
tion. However, the results do not preclude a possible1A). Thus, most of the cells carry at least one mutation,
impact on the accumulation of mutations by more dis-but there is a general shift toward a lower number of
tant cellular disruptions caused by the MSH2 deficiency.accumulated mutations in individual mutated cells. This
We therefore analyzed aspects of B cell maturation andis reminiscent of the pattern of mutation in young mice
function in Msh22/2 mice to see if there were signs of(GonzaÂ lez-FernaÂ ndez et al., 1994a) and is consistent
immune system dysfunction that could not simply bewith the idea that germinal center B cells in MSH2-
ascribed to impaired hypermutation.deficient mice undergo fewer rounds of hypermutation.
The germinal centers of spleens in MSH2-deficientOther explanations can also be envisaged.
mice were normal in size and appearance (Figure 2A),
and indeed the proportion of Peyer's patch B cells stain-
Increased Focusing of Mutation ing brightly with fluoresceinated peanut agglutinin was
on Intrinsic Hot Spots similar to that in controls (data not shown). However,
When the distribution of mutations along the JH flank is development of the specific immune response was im-
compared in normal and MSH2-deficient mice, a striking paired. Following secondary immunization with NP-CG,
difference emerges (Figure 1C). Compared to their lit- the titre of good-affinity IgG1 anti-NP antibody (as
termate controls, a large proportion of the nucleotide judged by ELISA titration on NP2.5-BSA coated plates)
substitutions in the Msh22/2 database are found to be was diminishedÐa phenomonenon which could con-
focused on a small number of positions. These positions ceivably be ascribable to impaired hypermutation (Fig-
reflect intrinsic mutational hot spots (Betz et al., 1993; ure 3A). But even at day 8 and 12 following primary
Jolly et al., 1997) whose sequences conform well to the immunization, we found a substantially diminished se-
RGYW (R, purine; Y, pyrimidine; W, A/T) consensus of rum titre of IgG1 (but not IgM) anti-NP antibody (as
Rogozin and Kolchanov (1992), and this increased hot judged by ELISA on NP30-BSA-coated plates so as to
spot targeting is a feature of all three MSH2-deficient detect low-affinity antibody [Figure 3B]).
mice analyzed (Table 2). It is difficult to see how this No gross effects on proliferative responses of MSH2-
deficient splenic B cells in these animals were detectedhot spot targeting could simply be a consequence of the
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Figure 1. Analysis of Hypermutation
(A) Distribution of mutations in Peyer's
patches germinal center B cells from Msh22/2
and Msh21/2 mice. Results are presented
from two sets of litters. Litter A was 14 weeks
old and spent its last 3 weeks housed in a
conventional animal facility; litter B was 5
weeks old. The area of each sector in the pie
charts represents the proportion of clones
with the indicated number of mutations; the
total number of clones analyzed is indicated
in the central circle of each pie.
(B) Schematic representation of the segment
of the JH4-Cm intron analyzed for mutations.
For PCR amplification, a consensus primer in
the framework 3 of the VHJ558 family was
used together with a primer in the IgH-intron
enhancer.
(C) Mutation patterns in endogenous JH4
flanking sequence of Msh21/2 (above the zero
line) and Msh22/2 (below the zero line) mice.
Variability (given as the percentage of clones
with a mutation at that position) is given for
each nucleotide position, with position 11
being the first nucleotide of the JH4-Cm intron.
The major hot spots are indicated by their
nucleotide position numbers.
(Figure 3C). This parallels observations made with non- consider here how these findings relate to observations
made by others on hypermutation in mismatch repair±lymphoid cells in the same line of mice (de Wind et al.,
1995). However, we did observe consistent changes in deficient mice and what insight the results give to the
possible involvement of mismatch repair in the creation/B cell subpopulations. Thus, the IgM1, IgD1 splenic B
cells of MSH2-deficient mice showed a shift toward in- fixation of nucleotide substitutions during antibody hy-
permutation.creased surface IgM expressionÐtypically taken as a
sign of decreased maturity (Figure 2B). Also striking was
the fact that in the bone marrow there was a marked Mutation Accumulation
Our finding of a substantially diminished level of hyper-diminution in the proportion of IgM1, IgD1, CD45R
(B220)high B cells, which are clasically identified as ma- mutation does not parallel the results of Phung et al.
(1998) and Jacobs et al. (1998), who found little effectture recirculating B cells (Figure 2C). Thus, there are
some clear differences between the B cells and B cell of Msh2 disruption on the mutation frequency in MSH2-
deficient mice. However, the diminished mutation fre-responses of MSH2-deficient and control mice that are
difficult to ascribe directly to impaired hypermutation. quency that we see is very similar to that first reported
by Cascalho et al. (1998) for PMS2-deficient mice. We
believe the explanation for the discrepancy lies in theDiscussion
method of analysis. In the approach used here (and
probaly in that of Cascalho et al. [1998]), one is essen-The work described here reveals that MSH2-deficient
mice exhibit impaired mutation accumulation and in- tially taking a snapshot view of the frequency of muta-
tions in the responses to diverse antigens, with thesecreased focusing of the residual mutations on the intrin-
sic hot spots; the mice also exhibit significant changes responses presumably being at various stages of matu-
ration. Here we see reduced frequency of mutation.in B cell subpopulations and immune responses. We
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Table 3. Nucleotide Targeting ComparisonTable 2. Distribution of Mutations in Hot Spots versus
Background
Excluding Hot Spots
CompilationMutations
Msh22/2 Msh21/2 Database Msh22/2 Msh21/2
Position Msh21/2 Msh2/2
T 7% 18% 20% 10% 20%
C 30% 26% 23% 20% 23%39 TGT 2.1% (11) 4.6% (7)
56 AGC 2.7% (14) 9.3% (14) A 19% 34% 33% 27% 38%
G 43% 22% 24% 44% 19%62 GCA 1.8% (9) 4.6% (7)
253 GCT 1.6% (8) 6.6% (10)
The table gives the percentage of the total mutations in each data-
base that have occurred in each of the four bases as analyzed on8.2% (42) 25.1% (38)
the coding strand. The compilation database (which is formed from
Mutations at each hotspot are given as the percentage of total V gene, non±V gene, and V gene±flanking mutations, totaling 2803
mutations that are located at that hot spot; the absolute number of mutations in .0.19 Mb of total DNA target analyzed) is taken from
such mutations in the database is provided in parentheses. Hot Milstein et al. (1998).
spots are defined here as nucleotide positions at which 15% of
the sequences from Msh21/2 mice carry a mutation. No significant
difference in the proportion of the total mutations located in the of mutation or to a decreased number of cycles. Thefour major hot spots indicated was apparent when the control mice
two cases could prove fundamentally different since one(5 and 14 weeks of age) were analyzed separately (6.7% and 9.1%
likely addresses the mechanics of hypermutation, theof the mutations found in the hot spots). Furthermore, all three
other, the cellular kinetics.Msh21/2 mice, when analyzed individually, revealed a preferential
accumulation of mutations in the four hot spots as compared to the A reduced extent of mutation accumulation in mis-
controls. match repair±deficientmice could therefore, as first sug-
gested by Cascalho et al. (1998), indicate a role for
mismatch repair in the hypermutation process itself.
However, if, as in Phung et al. (1998), one looks at the However, PMS2 and MSH2 deficiency affects multiple
number of mutations in antigen-selected hybridomas aspects of biology. For example, the Msh22/2 mice de-
derived during the secondary response to a specific velop T cell tumors at young age (de Wind et al., 1995)
antigen, then it may well be that those cells that have and, as shown here, they have a reduced number of
survived the specific selection criteria do not show such recirculating B cells in bone marrow, with their splenic
a marked reduction in mutation. B cells shifted to increased IgM expression. Immune
A reduced overall mutation frequency could, in princi- responses are also affected. Thus, while reduced muta-
ple, be due to a decreased proportion of cells having tion accumulation could reflect a role for mismatch re-
undergone the hypermutation process at all or to a di- pair in mutation, it could equally reflect ectopic effects
minished extent of mutation accumulation in those cells such as increased DNA damage or decreased T cell
within the otherwise normally targeted mutated popula- help causing germinal center B cells to undergo fewer
tion. Our results favor the second interpretation. This is rounds of hypermutation. However, the altered pattern
particularly illustrated by the analysis of young mice of mutational targeting in MSH2-deficient mice strongly
where the proportion of unmutated cells is similar in suggests a role for MSH2 in the mechanics of mutation
Msh21/2 and Msh22/2 littermates; the difference lies in creation/fixation during hypermutation. Thus, taken to-
the number of mutations accumulated within the mu- gether, it could well be that the diminished mutation
tated cell population. A reduced accumulation of muta- frequency in MSH2-deficient mice reflects both altered
tions in the targeted cells could then be due to a de- mechanics of hypermutation and altered cellular dy-
namics.creased number of mutations incorporated in each cycle
Figure 2. B Cell Populations
(A) Histological analysis to detect germinal
centers (GCs) was performed on splenic sec-
tions of MSH2-deficient and control lit-
termates prepared 14 days after immuniza-
tion with NP-CG. GCs were revealed by
staining with biotinylated peanut agglutinin.
No difference in GC size or number was de-
tected when comparing immunized MSH2-
deficient mice to the immunized controls.
(B) Flow cytometric analysis of bone marrow
cells stained with FITC-conjugated anti-mouse
IgM and either PE-conjugated anti-IgD or PE-
conjugated RA3-6B2 anti-CD45R (B220) MAb.
Mature, recirculating B cells have an IgM1,
IgD1, CD45R(B220)high phenotype and would
be expected to be found in areas R1 and R3.
The profiles shown are representative of six
mice analyzed, and the mean percentage of
cells (6 SEM) found within the designated
areas in these six animals is indicated below
each profile.
(C) Flow cytometric analysis of spleen cells stained with FITC-conjugated anti-IgM and PE-conjugated anti-CD45R(B220). The more mature
IgM1, IgD1 splenic B cells are usually taken to be IgMlow and would be contained within area R5.
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Figure 4. Two Models that Could Account for the Different Pattern
of Mutations Observed in MSH2-Deficient and Normal Mice
(A) Hypermutation preferentially creates nucleotide substitutions at
G/C residues, but MSH2-dependent mismatch repair also preferen-
tially corrects mismatches at G and C. This is the model put forward
by Phung et al. (1998). Additional effects of the Msh2 disruption
would need to be invoked to account for the diminished frequency
of mutation that we observe in MSH2-deficient mice.
(B) Mutation creation itself is viewed as a two-stage process. The
first stage is MSH2 independent and is strongly biased toward major
intrinsic hot spots (which tend to be at G or C). The second stage,
triggered by events occurring at the hot spots, introduces new muta-
tions with an A/T bias in other parts of the target by error-prone
DNA synthesis. This second stage is dependent on MSH2; in the
absence of MSH2, diminished mutation accumulation and increased
hot spot focusing would be anticipated.
with a second, Msh2-dependent phase that drives a
wider mutation distribution, so redressing the balance
of hot spot versus background and G/C versus A muta-
tions.
The nucleotide substitutions created by somatic hy-
permutation are nonrandomly distributed (Berek and
Milstein, 1987). There is a general preference for muta-
tions to be introduced at an RGYW consensus (Rogozin
and Kolchanov, 1992) but, over and above this, a number
of positions (which usually conform to the RGYW or
TA consensus) constitute intrinsic mutational hot spots
(Sharpe et al., 1991; Betz et al., 1993; GonzaÂ lez-FernaÂ n-
Figure 3. B Cell Responses dez et al., 1994b; Reynaud et al., 1995; Goyenechea
and Milstein, 1996; DoÈ rner et al., 1998; Klix et al., 1998;(A) Titres of IgG1 anti-NP antibody in the sera of NP-CG immu-
nized mice analyzed by ELISA on NP2.5-BSA. The bars (black bars, Milstein et al., 1998). The significance of these hot spots
Msh21/2; gray bars, Msh22/2) give the mean titres 6 SEM (n 5 8 for is unknown: their local sequence environment could fa-
the primary rsponse; n 5 4 for the secondary). Titres are given in vor nucleotide misincorporation by an error-prone poly-
arbitrary units based on multiplying OD readings in the ELISA by
merase or allow diminished efficacy of mismatch repair.the relevant serum dilution factor.
Alternatively, their location could be highlighting sites(B) Titres of IgM and IgG1 anti-NP antibody in the sera of NP-CG
immunized mice were analyzed by ELISA on NP30-BSA on the same at which the hypermutation process is initiated.
mice (n 5 8) as in (A). Major hot spots are at G/C positions and therefore
(C) Proliferative responses of splenocytes from Msh21/2 (black bars) the increased hot spot targeting that we observe and
and Msh22/2 mice (gray bars) to IL4 6 F(ab9)2 goat anti-m were the bias toward G/C mutation (Jacobs et al., 1998; Phung
assayed by monitoring incorporation of [3H]thymidine following a
et al., 1998) discussed by Phung et al. (1998) could, in48 hr culture. Each column represents the mean of three mice.
some sense, be two sides of the same coin. Indeed, the
increased mutation at G/C identified by Phung et al.
(1998) can in fact be ascribed to greatly increased muta-
tion at the Ser-31 and Ser-77 codons in their VkOx-1Hot Spot Targeting
The hypermutation in MSH2-deficient mice shows a target gene; these sites are known to be the major intrin-
sic hot spots of VkOx-1 (Betz et al., 1993). Equally, how-greatly increased focusing on the intrinsic hot spots.
We do not see how this effect can be readily ascribed ever, the increased hot spot focusing that we observe
could be a consequence of an overall increase in theto an alteration of extraneous aspectsof cellular physiol-
ogy, but we believe it reflects an effect of the Msh2 G/C bias of the mutational process in MSH2-deficient
mice.disruption on the mechanics of the process of mutation
creation/fixation during hypermutation. Indeed, the re- Phung et al. propose that the G/C bias of mutations
in Msh22/2 mice reveals that mutation introduction issults point to there being an Msh2-independent phase
of mutation targeting that is highly focused on hot spots, highly G/C biased and that MSH2 normally serves a
Immunity
140
59-terminal 16 residues of the JH4 segment). All analysis of hot spotsrole in preferentially correcting mismatches at G and
and mutation bias was performed onrestricted data after eliminationC (Figure 4A). Such a model could also account for
of clonally related sequences identified on the basis of shared VDJincreased hot spot focusing. Even then, a major implica-
rearrangements. The maximun PCR error for the described condi-
tion of our results would still be that mutational targeting tions was estimated (by sequencing clones from fractionated PNAlow
at the stage of mutation creation is much more focused B cells) to be less than 0.8 3 1023.
on the intrinsic hot spots that has been recognized here-
Analysis of B Cells and Responsestofore.
For immunization, mice (8±12 weeks old) were challenged intraperi-However, given the finding of hot spot focusing, it is
toneally with NP13-CG (Solid Phase Sciences, San Rafael, CA) thattempting to consider models other than that proposed
had been alum precipitated and boosted 24 days later. ELISAs were
by Phung et al. (1998). An alternative scenario we pro- performed on either NP30-BSA- or NP2.5-BSA-coated plates using
pose (Figure 4B) is that mutation creation at hot spots biotinylated anti-IgM and IgG1antibodies (Pharmingen) (Herzenberg
occurs by a mechanism distinct from that applying in et al., 1980). Analysis of B cell subpopulations was done using
PE-conjugated rat RA3±6B2 monoclonal anti-mouse CD45R(B220)the rest of the hypermutation target. For example, nucle-
antibody (GIBCO) and fluoresceinated anti-mouse IgM or IgD (Phar-otide substitutions could initially be introduced at hot
mingen); analysis of proliferative responses using F(ab9)2 goat anti-spots and sensed by MSH2, which then, in attempting
mouse m (Jackson) was performed as previously described (O'Keefe
to repair the hot spot mutations, brings into play an et al., 1996).
error-prone polymerase that creates mutations outside
the hot spots. The distinction between mutations cre- Acknowledgments
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